Literature DB >> 19675030

Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients.

T Balaguer1, S David, T Ihrai, N Cardot, G Daideri, E Lebreton.   

Abstract

Dupuytren's disease has a high rate of recurrence after treatment. In this study we have assessed the usefulness of histological staging in the prediction of recurrence. We have also verified whether there is a correlation between histological staging and features of Dupuytren's diathesis. We studied 139 hands in 124 Caucasian patients treated between 1997 and 2004. There was a significant difference in the recurrence rate between the three histological types (P = 0.04). Histological staging was independent of features of Dupuytren's diathesis. This study confirms that histological staging is a reliable method for predicting recurrence. However, it should be used in association with clinical data to determine precisely the prognosis of patients suffering from Dupuytren's contracture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675030     DOI: 10.1177/1753193409103729

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  13 in total

1.  A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture.

Authors:  Neal C Chen; Ramesh C Srinivasan; Melissa J Shauver; Kevin C Chung
Journal:  Hand (N Y)       Date:  2011-03-01

Review 2.  Dupuytren's disease: current state of the art.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2014-03

3.  Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.

Authors:  Rujue Jin; Weigang Zhu; Jiajun Xu; Jianhui Gu; Aidong Deng
Journal:  Gene Ther       Date:  2022-03-28       Impact factor: 5.250

Review 4.  Dupuytren's Disease-Etiology and Treatment.

Authors:  Mike Ruettermann; Robert Michael Hermann; Karl Khatib-Chahidi; Paul M N Werker
Journal:  Dtsch Arztebl Int       Date:  2021-11-19       Impact factor: 8.251

5.  Seven-year clinical outcomes after collagenase injection in patients with Dupuytren's disease: A prospective study.

Authors:  Rocco De Vitis; Marco Passiatore; Andrea Perna; Silvia Careri; Vitale Cilli; Giuseppe Taccardo
Journal:  J Orthop       Date:  2020-03-29

6.  Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts.

Authors:  Christopher Bainbridge; Lars B Dahlin; Piotr P Szczypa; Joseph C Cappelleri; Daniel Guérin; Robert A Gerber
Journal:  Eur Orthop Traumatol       Date:  2012-03-06

7.  3-Dimensional fasciectomy: A highly efficacious common ground approach to Dupuytren's surgery.

Authors:  Benjamin H Miranda; Charlotte Elliott; Christopher C Kearsey; David N Haughton; Mark R Webb; Ian Harvey; Fahmy S Fahmy
Journal:  Arch Plast Surg       Date:  2018-11-15

8.  Use of Acellular Dermal Matrix Following Fasciectomy for the Treatment of Dupuytren's Disease.

Authors:  Don Hoang; Patrick Steven; Vivi W Chen; Ashley Stasiak; Myles Cohen; David A Kulber
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-23

Review 9.  Systematic review of non-surgical treatments for early dupuytren's disease.

Authors:  Catherine Ball; David Izadi; Liaquat Suleman Verjee; James Chan; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2016-08-15       Impact factor: 2.362

10.  Radial extracorporeal shock wave therapy: a novel approach for the treatment of Dupuytren's contractures: A case report.

Authors:  Stefano Brunelli; Cinzia Bonanni; Marco Traballesi; Calogero Foti
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.